Maojie Yang

3.1k total citations · 3 hit papers
20 papers, 2.3k citations indexed

About

Maojie Yang is a scholar working on Immunology, Molecular Biology and Oncology. According to data from OpenAlex, Maojie Yang has authored 20 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Immunology, 8 papers in Molecular Biology and 7 papers in Oncology. Recurrent topics in Maojie Yang's work include Immunotherapy and Immune Responses (5 papers), Multiple Myeloma Research and Treatments (3 papers) and Cancer, Lipids, and Metabolism (3 papers). Maojie Yang is often cited by papers focused on Immunotherapy and Immune Responses (5 papers), Multiple Myeloma Research and Treatments (3 papers) and Cancer, Lipids, and Metabolism (3 papers). Maojie Yang collaborates with scholars based in United States, China and India. Maojie Yang's co-authors include Jianfei Qian, Qing Yi, Enguang Bi, Xingzhe Ma, Lintao Liu, Qiang Wang, Liuling Xiao, Su Pan, Lingqun Ye and Chunjian Huang and has published in prestigious journals such as Journal of Clinical Investigation, Nature Communications and The Journal of Experimental Medicine.

In The Last Decade

Maojie Yang

19 papers receiving 2.3k citations

Hit Papers

Cholesterol Induces CD8+ T Cell Exhaustion in the Tumor M... 2019 2026 2021 2023 2019 2021 2020 200 400 600

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Maojie Yang United States 14 1.0k 962 957 671 546 20 2.3k
Xingzhe Ma China 19 1.1k 1.1× 1.1k 1.1× 1.2k 1.2× 770 1.1× 556 1.0× 25 2.6k
Dominique C. Hinshaw United States 8 708 0.7× 1.2k 1.2× 887 0.9× 989 1.5× 669 1.2× 23 2.4k
Zhanlong Shen China 28 716 0.7× 1.2k 1.3× 742 0.8× 1.1k 1.7× 488 0.9× 93 2.7k
Ming Lü China 20 553 0.6× 812 0.8× 622 0.6× 449 0.7× 228 0.4× 40 1.7k
Elena Levantini United States 22 536 0.5× 1.6k 1.7× 1.0k 1.1× 785 1.2× 339 0.6× 48 3.0k
Chongbiao Huang China 26 598 0.6× 824 0.9× 439 0.5× 765 1.1× 261 0.5× 49 1.7k
Jianjie Zhu China 25 713 0.7× 1.1k 1.1× 526 0.5× 864 1.3× 437 0.8× 63 2.1k
Eriko Katsuta United States 24 501 0.5× 773 0.8× 372 0.4× 695 1.0× 403 0.7× 82 1.6k
Jaclyn Sceneay Australia 18 756 0.8× 1.2k 1.3× 1.0k 1.1× 1.4k 2.1× 607 1.1× 21 2.7k
Kathryn E. Beckermann United States 23 483 0.5× 898 0.9× 679 0.7× 920 1.4× 622 1.1× 57 2.0k

Countries citing papers authored by Maojie Yang

Since Specialization
Citations

This map shows the geographic impact of Maojie Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maojie Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maojie Yang more than expected).

Fields of papers citing papers by Maojie Yang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Maojie Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maojie Yang. The network helps show where Maojie Yang may publish in the future.

Co-authorship network of co-authors of Maojie Yang

This figure shows the co-authorship network connecting the top 25 collaborators of Maojie Yang. A scholar is included among the top collaborators of Maojie Yang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Maojie Yang. Maojie Yang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Qian, Jianfei, Qiang Wang, Liuling Xiao, et al.. (2024). Development of therapeutic monoclonal antibodies against DKK1 peptide-HLA-A2 complex to treat human cancers. Journal for ImmunoTherapy of Cancer. 12(1). e008145–e008145. 3 indexed citations
3.
Wang, Qiang, Zhijuan Lin, Zhuo Wang, et al.. (2021). RARγ activation sensitizes human myeloma cells to carfilzomib treatment through the OAS-RNase L innate immune pathway. Blood. 139(1). 59–72. 16 indexed citations
4.
Ma, Xingzhe, Liuling Xiao, Lintao Liu, et al.. (2021). CD36-mediated ferroptosis dampens intratumoral CD8+ T cell effector function and impairs their antitumor ability. Cell Metabolism. 33(5). 1001–1012.e5. 664 indexed citations breakdown →
5.
Zhou, Meng, et al.. (2021). EZH2 upregulates the expression of MAPK1 to promote intervertebral disc degeneration via suppression of miR‐129‐5p. The Journal of Gene Medicine. 24(3). e3395–e3395. 22 indexed citations
6.
Su, Pan, Qiang Wang, Enguang Bi, et al.. (2020). Enhanced Lipid Accumulation and Metabolism Are Required for the Differentiation and Activation of Tumor-Associated Macrophages. Cancer Research. 80(7). 1438–1450. 360 indexed citations breakdown →
7.
Li, Rong, Chengyun Zheng, Qiang Wang, et al.. (2020). Identification of an immunogenic DKK1 long peptide for immunotherapy of human multiple myeloma. Haematologica. 106(3). 838–846. 5 indexed citations
8.
Liu, Lintao, Enguang Bi, Xingzhe Ma, et al.. (2020). Enhanced CAR-T activity against established tumors by polarizing human T cells to secrete interleukin-9. Nature Communications. 11(1). 5902–5902. 72 indexed citations
9.
Wang, Qiang, Dongyu Zhao, Miao Xian, et al.. (2020). MIF as a biomarker and therapeutic target for overcoming resistance to proteasome inhibitors in human myeloma. Blood. 136(22). 2557–2573. 38 indexed citations
10.
Ma, Xingzhe, Enguang Bi, Yong Lu, et al.. (2019). Cholesterol Induces CD8+ T Cell Exhaustion in the Tumor Microenvironment. Cell Metabolism. 30(1). 143–156.e5. 697 indexed citations breakdown →
11.
Yang, Maojie, et al.. (2019). Sirtuin 2 expression suppresses oxidative stress and senescence of nucleus pulposus cells through inhibition of the p53/p21 pathway. Biochemical and Biophysical Research Communications. 513(3). 616–622. 41 indexed citations
12.
Qian, Jianfei, Qiang Wang, Lintao Liu, et al.. (2019). Development of an Immunotherapeutic Monoclonal Antibody Recognizing DKK1-HLA-A2 Complex to Treat Human Hematologic Malignancies. Blood. 134(Supplement_1). 5551–5551. 1 indexed citations
13.
Ma, Xingzhe, Enguang Bi, Chunjian Huang, et al.. (2018). Cholesterol negatively regulates IL-9–producing CD8+ T cell differentiation and antitumor activity. The Journal of Experimental Medicine. 215(6). 1555–1569. 118 indexed citations
14.
Bi, Enguang, Rong Li, Laura Bover, et al.. (2018). E-cadherin expression on multiple myeloma cells activates tumor-promoting properties in plasmacytoid DCs. Journal of Clinical Investigation. 128(11). 4821–4831. 31 indexed citations
15.
Sutton, Margie N., Hailing Yang, Gilbert Y. Huang, et al.. (2018). RAS-related GTPases DIRAS1 and DIRAS2 induce autophagic cancer cell death and are required for autophagy in murine ovarian cancer cells. Autophagy. 14(4). 637–653. 46 indexed citations
16.
Bi, Enguang, Xingzhe Ma, Yong Lu, et al.. (2017). Foxo1 and Foxp1 play opposing roles in regulating the differentiation and antitumor activity of T H 9 cells programmed by IL-7. Science Signaling. 10(500). 50 indexed citations
17.
Li, Yi, Yuhuan Zheng, Tianshu Li, et al.. (2015). Chemokines CCL2, 3, 14 stimulate macrophage bone marrow homing, proliferation, and polarization in multiple myeloma. Oncotarget. 6(27). 24218–24229. 60 indexed citations
18.
Lü, Zhen, Maria T. Baquero, Hailing Yang, et al.. (2014). DIRAS3 regulates the autophagosome initiation complex in dormant ovarian cancer cells. Autophagy. 10(6). 1071–1092. 55 indexed citations
19.
Zheng, Yuhuan, Qiang Wang, Jianfei Qian, et al.. (2014). Macrophage Migration Inhibitory Factor Regulates Multiple Myeloma Bone Marrow Homing. Blood. 124(21). 2015–2015. 1 indexed citations
20.
Li, Yi, Yuhuan Zheng, Li Yang, et al.. (2014). Chemokines CCL14 and CCL3 Facilitate Monocytes/Macrophage Infiltration in Multiple Myeloma Bone Marrow. Blood. 124(21). 3380–3380.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026